Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200399130> ?p ?o ?g. }
- W4200399130 endingPage "190" @default.
- W4200399130 startingPage "184" @default.
- W4200399130 abstract "Objective To evaluate the complementary value of urinary MyProstateScore (MPS) testing and multiparametric MRI (mpMRI) and assess outcomes in patients with equivocal mpMRI. Materials and Methods Included patients underwent mpMRI followed by urine collection and prostate biopsy at the University of Michigan between 2015 –2019. MPS values were calculated from urine specimens using the validated model based on serum PSA, urinary PCA3, and urinary TMPRSS2:ERG. In the PI-RADS 3 population, the discriminative accuracy of PSA, PSAD, and MPS for GG≥2 cancer was quantified by the AUC curve. Decision curve analysis was used to assess net benefit of MPS relative to PSAD. Results There were 540 patients that underwent mpMRI and biopsy with MPS available. The prevalence of GG≥2 cancer was 13% for PI-RADS 3, 56% for PI-RADS 4, and 87% for PI-RADS 5. MPS was significantly higher in men with GG≥2 cancer [median 44.9, IQR (29.4 –57.5)] than those with negative or GG1 biopsy [median 29.2, IQR (14.8 –44.2); P <.001] in the overall population and when stratified by PI-RADS score. In the PI-RADS 3 population (n = 121), the AUC for predicting GG≥2 cancer was 0.55 for PSA, 0.62 for PSAD, and 0.73 for MPS. MPS provided the highest net clinical benefit across all pertinent threshold probabilities. Conclusion In patients that underwent mpMRI and biopsy, MPS was significantly associated with GG≥2 cancer across all PI-RADS scores. In the PI-RADS 3 population, MPS significantly outperformed PSAD in ruling out GG≥2 cancer. These findings suggest a complementary role of MPS testing in patients that have undergone mpMRI." @default.
- W4200399130 created "2021-12-31" @default.
- W4200399130 creator A5003311852 @default.
- W4200399130 creator A5009456527 @default.
- W4200399130 creator A5010930816 @default.
- W4200399130 creator A5012696622 @default.
- W4200399130 creator A5012794522 @default.
- W4200399130 creator A5027920712 @default.
- W4200399130 creator A5031506572 @default.
- W4200399130 creator A5033415518 @default.
- W4200399130 creator A5036961774 @default.
- W4200399130 creator A5039646183 @default.
- W4200399130 creator A5042083535 @default.
- W4200399130 creator A5042505411 @default.
- W4200399130 creator A5045308705 @default.
- W4200399130 creator A5056372279 @default.
- W4200399130 creator A5060220628 @default.
- W4200399130 creator A5061534204 @default.
- W4200399130 creator A5064561416 @default.
- W4200399130 creator A5064810797 @default.
- W4200399130 creator A5068238406 @default.
- W4200399130 creator A5068922056 @default.
- W4200399130 creator A5069379816 @default.
- W4200399130 creator A5081326167 @default.
- W4200399130 creator A5083968353 @default.
- W4200399130 creator A5084076921 @default.
- W4200399130 creator A5087451827 @default.
- W4200399130 date "2022-06-01" @default.
- W4200399130 modified "2023-10-18" @default.
- W4200399130 title "Urinary MyProstateScore (MPS) to Rule out Clinically-Significant Cancer in Men with Equivocal (PI-RADS 3) Multiparametric MRI: Addressing an Unmet Clinical Need" @default.
- W4200399130 cites W1573867559 @default.
- W4200399130 cites W1827911007 @default.
- W4200399130 cites W1970876554 @default.
- W4200399130 cites W1980762548 @default.
- W4200399130 cites W2037668591 @default.
- W4200399130 cites W2045030989 @default.
- W4200399130 cites W2061891797 @default.
- W4200399130 cites W2140632139 @default.
- W4200399130 cites W2146373036 @default.
- W4200399130 cites W2164364841 @default.
- W4200399130 cites W2171001108 @default.
- W4200399130 cites W2226880313 @default.
- W4200399130 cites W2230472428 @default.
- W4200399130 cites W2316242722 @default.
- W4200399130 cites W2340422569 @default.
- W4200399130 cites W2341689870 @default.
- W4200399130 cites W2577453388 @default.
- W4200399130 cites W2594750672 @default.
- W4200399130 cites W2602602904 @default.
- W4200399130 cites W2754426562 @default.
- W4200399130 cites W2775769660 @default.
- W4200399130 cites W2782883928 @default.
- W4200399130 cites W2784183204 @default.
- W4200399130 cites W2793905111 @default.
- W4200399130 cites W2801986443 @default.
- W4200399130 cites W2802738800 @default.
- W4200399130 cites W2805300595 @default.
- W4200399130 cites W2901859788 @default.
- W4200399130 cites W2941995248 @default.
- W4200399130 cites W2944759727 @default.
- W4200399130 cites W2947156307 @default.
- W4200399130 cites W2949637961 @default.
- W4200399130 cites W2973912681 @default.
- W4200399130 cites W2977262858 @default.
- W4200399130 cites W3010331388 @default.
- W4200399130 cites W3016483492 @default.
- W4200399130 cites W3027017122 @default.
- W4200399130 cites W3036607405 @default.
- W4200399130 doi "https://doi.org/10.1016/j.urology.2021.11.033" @default.
- W4200399130 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34906585" @default.
- W4200399130 hasPublicationYear "2022" @default.
- W4200399130 type Work @default.
- W4200399130 citedByCount "5" @default.
- W4200399130 countsByYear W42003991302022 @default.
- W4200399130 countsByYear W42003991302023 @default.
- W4200399130 crossrefType "journal-article" @default.
- W4200399130 hasAuthorship W4200399130A5003311852 @default.
- W4200399130 hasAuthorship W4200399130A5009456527 @default.
- W4200399130 hasAuthorship W4200399130A5010930816 @default.
- W4200399130 hasAuthorship W4200399130A5012696622 @default.
- W4200399130 hasAuthorship W4200399130A5012794522 @default.
- W4200399130 hasAuthorship W4200399130A5027920712 @default.
- W4200399130 hasAuthorship W4200399130A5031506572 @default.
- W4200399130 hasAuthorship W4200399130A5033415518 @default.
- W4200399130 hasAuthorship W4200399130A5036961774 @default.
- W4200399130 hasAuthorship W4200399130A5039646183 @default.
- W4200399130 hasAuthorship W4200399130A5042083535 @default.
- W4200399130 hasAuthorship W4200399130A5042505411 @default.
- W4200399130 hasAuthorship W4200399130A5045308705 @default.
- W4200399130 hasAuthorship W4200399130A5056372279 @default.
- W4200399130 hasAuthorship W4200399130A5060220628 @default.
- W4200399130 hasAuthorship W4200399130A5061534204 @default.
- W4200399130 hasAuthorship W4200399130A5064561416 @default.
- W4200399130 hasAuthorship W4200399130A5064810797 @default.
- W4200399130 hasAuthorship W4200399130A5068238406 @default.
- W4200399130 hasAuthorship W4200399130A5068922056 @default.
- W4200399130 hasAuthorship W4200399130A5069379816 @default.
- W4200399130 hasAuthorship W4200399130A5081326167 @default.